We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
-2.57%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+548.24%
AUM
$840B
AUM Growth
-$11.4B
Cap. Flow
+$21.2B
Cap. Flow %
2.53%
Top 10 Hldgs %
26.02%
Holding
4,905
New
147
Increased
3,717
Reduced
626
Closed
142

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1.02B
2
AAPL icon
Apple
AAPL
+$837M
3
AMZN icon
Amazon
AMZN
+$811M
4
KVUE icon
Kenvue
KVUE
+$761M
5
BX icon
Blackstone
BX
+$581M

Sector Composition

Rank Sector Weight
1 Technology 27.7%
2 Healthcare 13.07%
3 Financials 12.46%
4 Consumer Discretionary 10.84%
5 Industrials 8.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMRA
4601
DELISTED
Comera Life Sciences Holdings, Inc. Common Stock
CMRA
$22.4K ﹤0.01%
70,212
+10,204
+17% +$5.38K
OKYO
4602
OKYO Pharma
OKYO
$88.2M
$22.4K ﹤0.01%
+12,090
New +$20.3K
INCR
4603
Intercure
INCR
$57M
$22.4K ﹤0.01%
14,148
BURU
4604
DELISTED
NUBURU INC
BURU
$22.3K ﹤0.01%
322
-106
-25% -$10.6K
ARVL
4605
DELISTED
Arrival Ordinary Shares
ARVL
$22.3K ﹤0.01%
18,751
+8,716
+87% +$15.6K
NVIV
4606
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
$22.2K ﹤0.01%
18,677
+7,508
+67% +$9.34K
NOGN
4607
DELISTED
Nogin, Inc. Common Stock
NOGN
$22.1K ﹤0.01%
39,495
AMTI
4608
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
$21.9K ﹤0.01%
139,808
-3,801
-3% -$1.01K
RIBT
4609
DELISTED
RiceBran Technologies
RIBT
$21.9K ﹤0.01%
51,019
+17,204
+51% +$12.6K
KPRX icon
4610
Kiora Pharmaceuticals
KPRX
$11.3M
$21.9K ﹤0.01%
+4,135
New +$21.2K
GGE
4611
DELISTED
Green Giant Inc. Common Stock
GGE
$21.9K ﹤0.01%
20,468
SLGL icon
4612
Sol-Gel Technologies
SLGL
$269M
$21.9K ﹤0.01%
1,341
VIOT
4613
Viomi Technology
VIOT
$51.8M
$21.7K ﹤0.01%
21,467
NEXI
4614
DELISTED
NexImmune, Inc. Common Stock
NEXI
$21.6K ﹤0.01%
4,326
+1,857
+75% +$11.5K
MKUL
4615
DELISTED
Molekule Group, Inc. Common Stock
MKUL
$21.5K ﹤0.01%
148,442
+16,766
+13% +$24.9K
PRE icon
4616
Prenetics Global
PRE
$317M
$21.5K ﹤0.01%
2,983
SLNA
4617
DELISTED
Selina Hospitality PLC Ordinary Shares
SLNA
$21.2K ﹤0.01%
60,296
FWDI
4618
Forward Industries Inc
FWDI
$297M
$20.9K ﹤0.01%
2,710
WIMI
4619
WiMi Hologram Cloud
WIMI
$22.1M
$20.9K ﹤0.01%
2,899
LMDX
4620
DELISTED
LumiraDx Limited Common Shares
LMDX
$20.6K ﹤0.01%
86,680
+51,734
+148% +$19.6K
NCPL icon
4621
Netcapital
NCPL
$2.94M
$20.5K ﹤0.01%
+713
New +$33.3K
YTEN
4622
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
$20.4K ﹤0.01%
2,604
+1,152
+79% +$29K
ABVC icon
4623
ABVC BioPharma
ABVC
$26.3M
$20.3K ﹤0.01%
19,480
+5,552
+40% +$13.4K
PALI icon
4624
Palisade Bio
PALI
$330M
$20K ﹤0.01%
2,297
-519
-18% -$9.52K
TONX
4625
TON Strategy Co
TONX
$168M
$20K ﹤0.01%
143
+57
+66% +$12.8K

Similar funds

Geode Capital Management's Q3 2023 Portfolio in Review

As of Q3 2023, Geode Capital Management held 4,905 positions worth $840B, down 1.3% from $851B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Geode Capital Management's Q3 2023 filing shows 147 new, 3,717 increased, 626 reduced and 142 closed positions. Its largest new stake was Kenvue: 32,873,626 shares worth $659M. The largest sale was Johnson & Johnson, an estimated $438M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.

  • Geode Capital Management's largest Q3 2023 buy was Kenvue: 32,873,626 shares worth $659M.
  • Geode Capital Management added most to Microsoft in Q3 2023, an estimated $1.02B increase.
  • Geode Capital Management's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $438M.
  • Geode Capital Management fully exited Life Storage, Inc. in Q3 2023, selling an estimated $202M.
  • Geode Capital Management's ten largest holdings make up 26% of its $840B portfolio in Q3 2023.
  • Geode Capital Management opened 147 new positions and closed 142 in Q3 2023.
  • Geode Capital Management's portfolio value fell 1.3% quarter-over-quarter to $840B.

Based on Geode Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.